荃信生物-B完成配售500万股

Core Viewpoint - The company, 荃信生物-B (02509), has successfully completed a placement agreement, with all conditions met as of August 25, 2025 [1] Group 1: Placement Details - The placement agent has successfully placed a total of 5 million shares at a price of HKD 20.0 per share to a single subscriber, TruMed Health Innovation Fund LP [1] - The shares placed represent approximately 2.25% of the total issued shares immediately before the completion of the placement and approximately 2.20% of the total issued shares after the placement [1]